A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Investigational Drug Gaining Traction Online
The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Viewers are encouraged to message these profiles directly for supplier links, while also obtaining discount codes.
Active Commerce on Social Networks
Additionally, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Experts Express Concerns
However, physicians and chemists have cautions that the sale of what remains an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of unknown origin.
Some professionals said the popularity for retatrutide could be linked to the increasing price of approved weight loss treatments such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, prosecution or prison.
Platform Response and Content Removal
According to TikTok, the service has taken down violative material and banned associated keywords and query recommendations. The organization said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also discovered communities with up to 9,000 participants marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or administering at home.
Within moments of entering one group, a vendor posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or past usage.
Item Details and Pricing
Inside these groups, posts display dark colored packages with Royal Mail stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens usually sold at 160 pounds for 20mg. When asked how long a pen should last, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for Telegram stated it regularly monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting substances they cannot confirm. Even if the research behind this drug is sound, these digital products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service linked the surge in interest to current cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has already seen individuals harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”
Producer Position
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this point no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company experimental product not yet authorized … may expose users to possibly significant medical dangers”.
